myTomorrows’ Post

Our very own Laura Hinton Cox, Angela Sarmiento Betancourt, Jytte van Huijstee, and Molly Brooks are attending the #SCOPE Europe Conference on 29-30 October in Barcelona! ☀️ This two-day event brings together clinical innovation leaders, digital experts, and those responsible for planning and managing clinical trials across Europe and beyond. We’re looking forward to connecting with BioPharma professionals, patient advocacy groups, and healthcare professionals. 🚀 ➡️ If you’re attending, you won’t want to miss our presentation "What It Takes to Successfully Recruit Patients: An Integrated Platform Approach" by Jytte van Huijstee, on Tuesday, October 29th at 10:40 am. In this session, Jytte will dive into: ✔️Tackling challenges in clinical trial recruitment, such as patient and physician awareness, language barriers, cross-border referrals, and regulatory compliance. ✔️Developing an integrated platform that connects patients, physicians, and clinical sites for streamlined trial enrollment. ✔️Discovering tactics for engaging with different stakeholders through real-world success stories from treating physicians, patient advocacy groups, and clinical research sites. 👉 Visit us at Booth #49 or schedule a meeting with us for insightful discussions and to explore opportunities to collaborate: https://lnkd.in/eH9Dq28t We’re excited to learn, network, and bring back valuable insights to our team! 🌠 #SCOPEEurope #ClinicalTrials #PatientEngagement #RecruitmentStrategies #BioPharma #HealthcareInnovation

Spotlight on Duchenne Muscular Dystrophy (DMD) 🚨 Are you living with or caring for someone affected by Duchenne Muscular Dystrophy (DMD), or simply curious to know more about this condition? Our newest blog, part of our disease awareness series, focuses on this serious muscle disorder, which affects 6 out of every 100,000 individuals in Europe and North America. In this blog, you’ll learn about: ✔️What DMD is and how it’s diagnosed ✔️Common symptoms ✔️Current treatments that help manage symptoms and improve quality of life, such as physical exercise, assistive devices or heart monitoring ✔️Investigational therapies being studied in clinical trials, such as gene therapy and exon skipping treatments. ➡️ Read the full blog to learn more about Duchenne Muscular Dystrophy here https://lnkd.in/eEAGSr3p 👉 Visit our Patient Resources section to explore other blogs about this condition.https://eu1.hubs.ly/H0d4Xq50 #DuchenneMuscularDystrophy #DMD #myTomorrows #PatientResources #DiseaseAwareness #GeneTherapy #ExonSkipping

Counting down to World Orphan Drug Congress Europe!  🚀 Our very own Angela Sarmiento Betancourt and Laura Hinton Cox are attending the World Orphan Drug Congress Europe on 22-25 October in Barcelona, Spain! ☀️ As the largest and most established event for orphan drugs and rare diseases, this congress is the perfect opportunity to learn about the latest innovations in: ✔️Cell & Gene Therapy ✔️Genetic Testing ✔️Real-World Evidence ✔️ Market Access ✔️Orphan Drug Policies, and more! Our Mighties are looking forward to engaging with Biopharma Leaders, Patient Advocacy Groups, and Healthcare Professionals to spark insightful discussions and explore new collaboration opportunities. Also attending? We’d love to connect - book a meeting with us. https://lnkd.in/etVzb-Rg #WODC #Orphandrug #Raredisease #BioPharma #PAGs #HCPs

📢 Calling all BioPharma professionals! 🗓️ Save the date: 18th & 19th February 2025, Singapore. Join myTomorrows, Novartis, Roche, BeiGene for a new conference: ‘Pre-approval Access to Medicines in Asia-Pacific’. Together, we’ll navigate regulatory pathways, ethics, operations and regional challenges for pre-approval access within the Asia-Pacific (APAC) region. 🌏 We know countries in this region encounter diverse regulatory frameworks, differing healthcare infrastructures leading to different ethical and operational considerations. 💡 That’s why this forum will offer a crucial platform for disseminating knowledge, supportive strategies, and best practices to those involved. Participants will gain the tools and insights needed to achieve operational excellence and improve patient access to medicines. ➡️ Registration will open in a few short weeks so watch this space for more exciting updates about this new, first-of-its-kind conference. 🚀

Today is World Mental Health Day! ☀️ This year’s theme from the @World Health Organization is Mental Health at Work and highlights the important connection between mental well-being and productivity at work. In support, this week we’ve arranged series of activities for our Mighty Mighties, designed to promote connection, reflection and support within our team. 🌠 Here’s what’s in store… mindful exercises and guided meditation, creative spaces and opportunities to open up conversations in a safe and supportive space. 👏 Check out this photo of the team who took part in one of the activities to de-stress and reconnect! 💞 Fostering positive mental health both at work and in our private lives is incredibly important at myTomorrows and we’re committed to doing all we can to help and support staff to find a comfortable balance. 💪 #WorldMentalHealthDay #MentalHealthAtWork #MentalWellbeing #WorkplaceWellness #myTomorrows

Exciting News! 🚀 We are thrilled to announce that myTomorrows has been nominated for the Deloitte Technology Fast 50 2024 Award! This recognition as one of the 50 fastest-growing technology companies in the Netherlands is a true testament to the dedication, innovation, and hard work of our entire team. 👏 But that’s not all – we’re also very excited to be nominated for the Diverse & Inclusive Leadership Award. Promoting inclusivity and fostering a diverse workplace has always been key at myTomorrows, and being acknowledged for these efforts is truly an honor! ☀️ We can’t wait to see where we land in the final Fast 50 ranking, which will be revealed at the award show on November 7th. A big thank you to everyone who has supported us on this journey! 🌟 Stay tuned for the results! #Fast50 #TechnologyFast50 #DiversityAndInclusion #Innovation #Teamwork #Gratitude #myTomorrows

We’re live at the 3rd Operationalise: Early Access Programmes Summit Europe and excited to contribute to the discussions with industry partners on improving patient access through Early Access Programmes!🚀 Today at 3:30 PM BST, don’t miss our fireside chat for industry members on Supporting Pediatric Patient Populations: The Case for Expanded Access, where our very own Natalia Coptu and Karlijn Doorn, PhD will be joined by Dr. Uri Ilan (Prinses Maxima Centrum) and Anke Friedetzky (Pierre Fabre Group) to discuss about how to better support access for pediatric patient populations. Key takeaways will include: ✔️Understanding treatment gaps in pediatric care and how EAPs can bridge them ✔️Engaging with key stakeholders involved in pediatric Expanded Access ✔️Practical strategies from real-world case studies See you at 3:30 pm BST! ☀️ #EAPs #Globalregulations #ExpandedAccess #BioPharm #MedicalAccess

💼 Ready to make Mondays more meaningful? Dive into our latest job listings today. Become a part of our dynamic group of Mighties with diverse backgrounds in Medical, Pharma, Tech, and Business. This is an exciting opportunity to join our ambitious company as it grows. With benefits like flexible working, a learning and development budget, and an annual performance bonus, you’ll be based in Amsterdam with a fast-growing company of 80+ people, with 30 nationalities, helping patients to know all their treatment options. 💚 Senior Backend Engineer https://lnkd.in/epdU-N9M Patient Navigator (in Mexico) https://lnkd.in/eaDWyfxj Patient Navigator (in India) https://lnkd.in/eHjFmcca Our full list: https://lnkd.in/eTgxyuhn   #WeAreMighty #newjob #hiring

Happening TODAY! 🚀 The day is finally here! Join us today, October 3rd at 1:30pm EST/7:30pm CEST, for our much-anticipated panel discussion: "Unlocking LGMD2I Clinical Trials: A Patient and Caregiver’s Guide to Participating." ☀️ Our session will offer practical guidance on locating, accessing, and participating in clinical trials for those with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I), and an overview of all currently available clinical trials. 👥 Our expert panel features Kelly Brazzo (CEO of CureLGMD2i Foundation and LGMD patient caregiver/mother), Kat Bryant Knudson (Speak Foundation), Melissa Grove (LGMD Patient Advocate), and Terri Ellsworth (Patient Advocacy Liaison). Moderated by Dennis Akkaya (CCO at myTomorrows), this discussion will offer you insights into the current landscape of LGMD2I clinical trials. What you will learn: ✔️Gain a clear understanding of clinical trials and their role in LGMD2I treatments. ✔️Receive practical guidance on how to find and access information on clinical trials, including how to make informed decisions together with your healthcare providers. ✔️Learn key information on active LGMD2I clinical trials, including eligibility criteria and enrolment steps. ➡️ It’s not too late to join us! Register now and be part of this insightful discussion. https://lnkd.in/eci4KaMA We look forward to seeing you today! #LGMD2I #ClinicalTrials #HealthcareProfessionals #PAGs #PatientAdvocacy #RareDisease

We're excited to share that our Chief Commercial Officer, Dennis Akkaya, and Kelly Brazzo, CEO of the CureLGMD2i Foundation, were featured in an insightful interview in NeurologyLive! They talked about our new partnership, which aims to make clinical trials discovery more accessible for patients with Limb-Girdle Muscular Dystrophy (LGMD), a rare genetic condition characterized by progressive weakness and wasting of the muscles.🚀 🔬Currently, several new investigational treatments for LGMD, including gene therapy, are being studied in clinical trials. In the interview, Dennis and Kelly talked about the challenges faced by those LGMD patients seeking information about clinical trials to learn about their options. Publicly available information, such as online databases or public registries, can be overwhelming and hard to navigate for these patients. Additionally, since many trials target specific subtypes, patients who aren’t sure of their exact subtype can struggle to find the right match. As a result, many of these patients are left confused, unsure of which trials are available, whether they qualify, and how to enroll. 👏 Dennis and Kelly discussed how our partnership aims to address these issues by creating a more patient-friendly way to find relevant clinical trials. Through myTomorrows’ search engine, patients and physicians can more easily access global trial options, while patient navigators offer guidance and support throughout the journey, helping individuals make informed decisions with their physicians about their care.🌠 Together, we are committed to building a safe and reliable space where patients can ask questions and understand their options.☀️ Read the full interview here: https://lnkd.in/eRSk9UGW #LGMD #ClinicalTrials #RareDisease #NeurologyLive #Partnership #PatientCare #HealthTech #DrugDevelopment